DICE
DICE Therapeutics, Inc. Common Stock
DICE
DICE
Delisted
DICE was delisted on the 8th of August, 2023.
69 hedge funds and large institutions have $799M invested in DICE Therapeutics, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
69
Holders Change
+30
Holders Change %
+76.92%
% of All Funds
1.07%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.09%
New
40
Increased
9
Reduced
10
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BlackRock
New York
|
+$21.6M |
| 2 |
PA
Perceptive Advisors
New York
|
+$17.8M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$14.7M |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
+$12.8M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$6.34M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$14.5M |
| 2 |
O
OrbiMed
New York
|
-$14.4M |
| 3 |
Millennium Management
New York
|
-$7.7M |
| 4 |
ACA
Avoro Capital Advisors
New York
|
-$6.01M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$2.78M |
